CAPSULAR POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES OF VIBRIO VULNIFICUS

创伤弧菌荚膜多糖-蛋白结合疫苗

基本信息

  • 批准号:
    3748114
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Vibrio vulnificus causes fatal septicemic and wound infections in immunocompromised humans following raw oyster consumption or exposure of open wounds to oyster-harvested waters. The capsular polysaccharide of Vibrio vulnificus (VvPS) is believed to confer the property of invasiveness. With the objective of evaluating the pathogenic and protective roles of VvPS and other protein antigens of V. vulnificus, we synthesized conjugate vaccines of carbotype 1 VvPS with TT or inactivated cytolysin or elastase of V. vulnificus by two different schemes. The immunogenicity of these conjugates was evaluated in Swiss shite mice by subcutaneous injections in saline. All conjugates elicited higher capsular antibody responses than VvPS alone and induced elevated IgG and IgM responses. The conjugates prepared through carboxyl activation of VvPS (VvPS-TTa, VvPS-cytolysin and VvPS-elastase) were more immunogenic than the one prepared through hydroxyl activation (VvPS-TTb). Capsular antibody response was significantly enhanced by concurrent intraperitoneal administration of conjugates with MPL+TDM adjuvant.The individual and synergistic protective effects of VvPS, cytolysin and elastase alone and in conjugate vaccine forms were evaluated in a mouse septicemia model. VvPS-TTa vaccine conferred protection to 80% of actively immunized mice following intraperitoneal infection with -5 LD50 of carbotype 1 V. vulnificus, while the protection conferred by VvPS- cytolysin and VvPS-elastase was 40 and 44% respectively. VvPS-TTb was least protective. Control mice immunized with VvPS, cytolysin or elastase alone, VvPS followed by cytolysin, or saline only, showed 70- 100% mortality. Thus, VvPS-TTa is highly immunogenic and protective in mice, and appears suitable for clinical evaluation. Passive protection studies using VvPS-TTa-induced antisera are underway.
创伤弧菌引起致命的败血症和伤口感染

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

S DEVI其他文献

S DEVI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('S DEVI', 18)}}的其他基金

TRICHOSPORON BIEGELII PS CROSS REACTS WITH CRYPTOCOCCAL CAPSULAR ANTIGEN
Trichosporon BIEGELII PS 与隐球菌荚膜抗原发生交叉反应
  • 批准号:
    3748115
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
IMMUNE RESPONSE TO GROUP B MENINGOCOCCAL CAPSULAR POLYSACCHARIDE
对 B 组脑膜炎球菌荚膜多糖的免疫反应
  • 批准号:
    3748105
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
IMMUNE RESPONSE TO GROUP B MENINGOCOCCAL POLYSACCHARIDE
对 B 组脑膜炎球菌多糖的免疫反应
  • 批准号:
    3792319
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CAPSULAR POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES OF VIBRIO VULNIFICUS
创伤弧菌荚膜多糖-蛋白结合疫苗
  • 批准号:
    5200680
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PRECLINICAL SAFETY AND IMMUNOGENICITY OF GROUP B MENINGOCOCCAL VACCINES
B 组脑膜炎球菌疫苗的临床前安全性和免疫原性
  • 批准号:
    2568873
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
TRICHOSPORON BIEGELII PS CROSS REACTS WITH CRYPTOCOCCAL CAPSULAR ANTIGEN
Trichosporon BIEGELII PS 与隐球菌荚膜抗原发生交叉反应
  • 批准号:
    5200681
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PRECLINICAL SAFETY AND IMMUNOGENICITY OF GROUP B MENINGOCOCCAL VACCINES
B 组脑膜炎球菌疫苗的临床前安全性和免疫原性
  • 批准号:
    5200675
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
IMMUNE RESPONSE TO GROUP B MENINGOCOCCAL CAPSULAR POLYSACCHARIDE
对 B 组脑膜炎球菌荚膜多糖的免疫反应
  • 批准号:
    3770275
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Active immunization mouse model by cN1A peptides
cN1A肽主动免疫小鼠模型
  • 批准号:
    18K15370
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an efficient oocyte collection method using active immunization against inhibin in cynomolgus monkeys.
使用食蟹猴主动免疫抑制素开发有效的卵母细胞收集方法。
  • 批准号:
    17H06766
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Passive and Active Immunization for Pneumocystis
肺孢子虫的被动和主动免疫
  • 批准号:
    9182862
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    8136035
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    7921670
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
Can passive or active immunization alter the course of infection with circoviral DNA?
被动或主动免疫可以改变圆环病毒 DNA 的感染过程吗?
  • 批准号:
    306844-2004
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
    Special Research Opportunity Program - Project
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    7502083
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    7341002
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    7679096
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
Passive-Active Immunization Strategies Against Pediatric AIDS
针对儿童艾滋病的被动-主动免疫策略
  • 批准号:
    7065729
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了